Skip to main content

Raptor Pharmaceutical Corp. (NASDAQ:RPTP) Investor Investigation Over Executive Compensation Announced

  • If you are a current long-term stockholder of shares of Raptor Pharmaceutical Corp. (NASDAQ:RPTP), you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Investigation Overview

Jan. 29, 2013 (Shareholders Foundation) -- An investigation on behalf of current long term investors in shares of Raptor Pharmaceutical Corp. (NASDAQ:RPTP) was announced concerning whether certain officers and directors of Raptor Pharmaceutical Corp. breached their fiduciary duties by paying certain top officials at Raptor Pharmaceutical excessive compensation. The investigation by a ...



You must register (for free) or login to view the entire investigation.